MCID: PTY002
MIFTS: 36

Pityriasis Versicolor

Categories: Infectious diseases

Aliases & Classifications for Pityriasis Versicolor

MalaCards integrated aliases for Pityriasis Versicolor:

Name: Pityriasis Versicolor 12 51 14
Tinea Versicolor 41 69 59
Infection by Pityrosporum Furfur 12

Classifications:



External Ids:

Disease Ontology 12 DOID:9060
ICD10 32 B36.0
ICD9CM 34 111.0
MeSH 41 D014010
SNOMED-CT 64 154395007 56454009
UMLS 69 C0040262

Summaries for Pityriasis Versicolor

PubMed Health : 59
About tinea versicolor: Tinea versicolor, also referred to as pityriasis versicolor, is a skin condition characterized by small patches of lighter or darker skin. It is caused by a type of fungus that is found on almost everyone’s skin. It is generally not harmful and it isn't contagious.Topical treatments, such as special creams or shampoos, are usually effective.

MalaCards based summary : Pityriasis Versicolor, also known as tinea versicolor, is related to epidermodysplasia verruciformis and dermatitis. An important gene associated with Pityriasis Versicolor is CAT (Catalase). The drugs Ketoconazole and Miconazole have been mentioned in the context of this disorder. Affiliated tissues include skin, and related phenotypes are Negative genetic interaction between MUS81-/- and MUS81+/+ and Negative genetic interaction between PTTG1-/- and PTTG1+/+

Disease Ontology : 12 A superficial mycosis that is a chronic, superficial fungal infection of the skin caused by Malassezia furfur, which is characterized by well-demarcated white, pink, fawn, or brownish lesions, often coalescing, and covered with thin furfuraceous scales.

Wikipedia : 72 Tinea versicolor is a condition characterized by a skin eruption on the trunk and proximal extremities.... more...

Related Diseases for Pityriasis Versicolor

Diseases related to Pityriasis Versicolor via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 22)
# Related Disease Score Top Affiliating Genes
1 epidermodysplasia verruciformis 31.6 TMC6 TMC8
2 dermatitis 10.4
3 aging 10.3
4 erythrasma 10.2
5 seborrheic dermatitis 10.2
6 dermatitis, atopic 10.1
7 tinea cruris 10.1
8 pityriasis rotunda 10.1
9 beta-adrenergic stimulation, response to 9.9
10 blood group, i system 9.9
11 ige responsiveness, atopic 9.9
12 dowling-degos disease 1 9.9
13 leprosy 3 9.9
14 tinea corporis 9.9
15 tinea pedis 9.9
16 candidiasis 9.9
17 tinea capitis 9.9
18 dermatophytosis 9.9
19 hansen's disease 9.9
20 integumentary system cancer 9.9 TLR9 TMC8
21 chronic granulomatous disease 9.7 CAT TLR9
22 superficial mycosis 8.4 KRT31 STIM1 TLR9 TMC6 TMC8

Graphical network of the top 20 diseases related to Pityriasis Versicolor:



Diseases related to Pityriasis Versicolor

Symptoms & Phenotypes for Pityriasis Versicolor

GenomeRNAi Phenotypes related to Pityriasis Versicolor according to GeneCards Suite gene sharing:

25
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Negative genetic interaction between MUS81-/- and MUS81+/+ GR00255-A-2 9.13 KRT31 TMC6 TMC8
2 Negative genetic interaction between PTTG1-/- and PTTG1+/+ GR00255-A-4 8.8 KRT31 SQLE TMC8

Drugs & Therapeutics for Pityriasis Versicolor

PubMedHealth treatment related to Pityriasis Versicolor: 59

Tinea versicolor may improve a little in cool or dry weather, but it usually doesn’t go away on its own. There are a number of effective treatments. These mainly include creams, lotions and shampoos that contain antifungal substances. They are applied to all of the affected areas of skin on the head and body. The shampoo is used too, in order to get rid of the fungus on the scalp and hair. Otherwise it might spread back to the skin again. Depending on the exact product used, it needs to be left on for anywhere from a few minutes to several hours. The products are often put on in the evening and then rinsed off in the shower the next morning.But even when treatment works, it can take up to several weeks or months for the skin patches to disappear. Only in rare cases are tablets needed.Sometimes tinea versicolor comes back again after successful treatment. If this keeps happening, doctors sometimes recommend using a special shampoo (containing an active ingredient like selenium sulfide or ketoconazole) on your skin and hair every two to four weeks. There are also oral medications (tablets) that can be taken every four weeks to prevent tinea versicolor from returning. This can greatly reduce the risk of it coming back.

Drugs for Pityriasis Versicolor (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 11)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ketoconazole Approved, Investigational Phase 4 65277-42-1 3823 47576
2
Miconazole Approved, Investigational, Vet_approved Phase 4 22916-47-8 4189
3
Ciclopirox Approved, Investigational Phase 4 29342-05-0 2749
4 Steroid Synthesis Inhibitors Phase 4
5 Cytochrome P-450 CYP3A Inhibitors Phase 4
6 Cytochrome P-450 Enzyme Inhibitors Phase 4
7 Hormone Antagonists Phase 4
8 Hormones Phase 4
9 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4
10 Anti-Infective Agents Phase 4
11 Antifungal Agents Phase 4

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Ketoconazole Foam 2% for the Treatment of Versicolor Completed NCT00830388 Phase 4 Ketoconazole 2% Foam
2 Safety Study of Ciclopirox Olamine Cream for Dermatomycoses in Children Terminated NCT01646580 Phase 4 ciclopirox

Search NIH Clinical Center for Pityriasis Versicolor

Inferred drug relations via UMLS 69 / NDF-RT 47 :


Cochrane evidence based reviews: tinea versicolor

Genetic Tests for Pityriasis Versicolor

Anatomical Context for Pityriasis Versicolor

MalaCards organs/tissues related to Pityriasis Versicolor:

38
Skin

Publications for Pityriasis Versicolor

Articles related to Pityriasis Versicolor:

(show top 50) (show all 265)
# Title Authors Year
1
Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study. ( 29239242 )
2018
2
Correction to: Antifungal activity of Myrtus communis against Malassezia sp. isolated from the skin of patients with pityriasis versicolor. ( 29294237 )
2018
3
Atrophying Pityriasis Versicolor. ( 29249261 )
2017
4
Knowledge, perception, and practice of patients about pityriasis versicolor in Kaduna, North Central Nigeria. ( 28561308 )
2017
5
Molecular and Phenotypic Identification and Speciation of Malassezia Yeasts Isolated from Egyptian Patients with Pityriasis Versicolor. ( 28969121 )
2017
6
Correction to: El-Housiny etA al., Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study. ( 29260902 )
2017
7
Narrow-band UV-B phototherapy: an effective and reliable treatment alternative for extensive and recurrent pityriasis versicolor. ( 28984153 )
2017
8
Antifungal activity of Myrtus communis against Malassezia sp. isolated from the skin of patients with pityriasis versicolor. ( 29159502 )
2017
9
Atrophic pityriasis versicolor occurring in a patient with SjAPgren's syndrome. ( 28100575 )
2017
10
Recurrent and disseminated pityriasis versicolor: A novel clinical form consequent to Malassezia-host interaction? ( 29150273 )
2017
11
Comparative efficacy of topical application of tacrolimus and clotrimazole in the treatment of pityriasis versicolor: A single blind, randomised clinical trial. ( 28120351 )
2017
12
Atrophying pityriasis versicolor as an idiosyncratic TA cell-mediated response to Malassezia: A case series. ( 27816291 )
2016
13
The evaluation of local oxidative/nitrosative stress in patients with pityriasis versicolor: a preliminary study. ( 27329971 )
2016
14
Comparative clinical trial: fluconazole alone or associated with topical ketoconazole in the treatment of pityriasis versicolor. ( 27532525 )
2016
15
Comparative assessment of the efficacy of topical ketoconazole and topical luliconazole in cases of pityriasis versicolor at a tertiary care hospital in eastern India: A prospective, open, randomized controlled trial. ( 27559523 )
2016
16
In vitro antifungal susceptibility of Malassezia isolates from pityriasis versicolor lesions. ( 27852993 )
2016
17
Clinicomycological profile of pityriasis versicolor in Assam. ( 27166032 )
2016
18
Pityriasis versicolor atrophicans mit epidermaler Atrophie. ( 27373255 )
2016
19
Dermoscopy as an ancillary tool for the diagnosis of pityriasis versicolor. ( 26568350 )
2015
20
SIXTEEN YEARS OF PITYRIASIS VERSICOLOR IN METROPOLITAN AREA OF PORTO ALEGRE, SOUTHERN BRAZIL. ( 26422149 )
2015
21
Neonatal pityriasis versicolor. ( 25742084 )
2015
22
A randomized double-blind, non-inferiority Phase II trial, comparing dapaconazole tosylate 2% cream with ketoconazole 2% cream in the treatment of Pityriasis versicolor. ( 26419668 )
2015
23
Study of the Distribution of Malassezia Species in Patients with Pityriasis Versicolor in Kolar Region, Karnataka. ( 26120178 )
2015
24
Pityriasis versicolor. ( 25852089 )
2015
25
A Novel Contrast Stain for the Rapid Diagnosis of Pityriasis Versicolor: A Comparison of Chicago Sky Blue 6B Stain, Potassium Hydroxide Mount and Culture. ( 26288400 )
2015
26
Pityriasis versicolor atrophicans: Is it true atrophy or pseudoatrophy? ( 26488217 )
2015
27
A case of Becker's nevus with pityriasis versicolor. ( 24438156 )
2014
28
Distribution of Malassezia species in patients with pityriasis versicolor in Turkey. ( 24746716 )
2014
29
An analysis of the Malassezia species distribution in the skin of patients with pityriasis versicolor in Chengdu, China. ( 25177714 )
2014
30
Can pityriasis versicolor be treated with 2% ketoconazole foam? ( 25007370 )
2014
31
Perineal and genital pityriasis versicolor due to Malassezia globosa. ( 24814165 )
2014
32
Identification of Malassezia Species Isolated from Patients with Pityriasis Versicolor Using PCR-RFLP Method in Markazi Province, Central Iran. ( 26056657 )
2014
33
Atypical clinical manifestation of pityriasis versicolor in a young boy. ( 24819649 )
2014
34
Atrophying pityriasis versicolor. ( 24733760 )
2014
35
Pityriasis versicolor: a case of resistance to treatment. ( 23432729 )
2014
36
Terbinafin 1% Cream and Ketoconazole 2% Cream in the Treatment of Pityriasis Versicolor: A randomized comparative clinical trial. ( 25674122 )
2014
37
Influence of systemic corticotherapy on the triggering of pityriasis versicolor. ( 24724729 )
2014
38
A randomized controlled trial of combination treatment with ketoconazole 2% cream and adapalene 0.1% gel in pityriasis versicolor. ( 24802530 )
2014
39
A study of the prevalence and precipitating factors of pruritus in pityriasis versicolor. ( 24860771 )
2014
40
Pityriasis versicolor: an update on pharmacological treatment options. ( 24991691 )
2014
41
Molecular identification and prevalence of malassezia species in pityriasis versicolor patients from kashan, iran. ( 25485051 )
2014
42
Pityriasis versicolor: avoiding pitfalls in disease diagnosis and therapy. ( 23929053 )
2013
43
Identification and speciation of malassezia in patients clinically suspected of having pityriasis versicolor. ( 23723483 )
2013
44
Pityriasis versicolor: clinical-epidemiological characterization of patients in the urban area of Buerarema-BA , Brazil. ( 23739695 )
2013
45
Vulvar Pityriasis Versicolor in an Immunocompetent Woman. ( 24270201 )
2013
46
Study of the distribution of Malassezia species in patients with pityriasis versicolor and healthy individuals in Tertiary Care Hospital, Punjab. ( 23883714 )
2013
47
Molecular analysis of Malassezia species isolated from Israeli patients with pityriasis versicolor. ( 23347312 )
2013
48
Hair loss in pityriasis versicolor lesions: a descriptive clinicopathological study. ( 22575159 )
2013
49
Identification of Malassezia species isolated from patients with extensive forms of pityriasis versicolor in Siena, Italy. ( 23434513 )
2013
50
Molecular epidemiology of Malassezia globosa and Malassezia restricta in Sudanese patients with pityriasis versicolor. ( 23054329 )
2013

Variations for Pityriasis Versicolor

Expression for Pityriasis Versicolor

Search GEO for disease gene expression data for Pityriasis Versicolor.

Pathways for Pityriasis Versicolor

GO Terms for Pityriasis Versicolor

Cellular components related to Pityriasis Versicolor according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.46 CAT KRT31 TLR9 TMC8
2 endoplasmic reticulum membrane GO:0005789 9.35 SQLE STIM1 TLR9 TMC6 TMC8
3 endoplasmic reticulum GO:0005783 9.1 CAT SQLE STIM1 TLR9 TMC6 TMC8

Biological processes related to Pityriasis Versicolor according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 ion transport GO:0006811 9.43 STIM1 TMC6 TMC8
2 positive regulation of NF-kappaB transcription factor activity GO:0051092 9.16 CAT TLR9
3 cholesterol metabolic process GO:0008203 8.96 CAT SQLE
4 negative regulation of NF-kappaB transcription factor activity GO:0032088 8.62 CAT TLR9

Sources for Pityriasis Versicolor

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....